NEW YORK (GenomeWeb News) – OriGene Technologies and SDIX today announced a definitive agreement for OriGene to buy the Life Science assets of SDIX for $16 million.

OriGene is acquiring substantially all of SDIX's assets and will offer employment to a "substantial majority" of SDIX's employees, SDIX said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.